VOLITIONRX LTD's ticker is VNRX and the CUSIP is 928661107. A total of 57 filers reported holding VOLITIONRX LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,600 | -50.4% | 15,384 | 0.0% | 0.00% | – |
Q2 2023 | $21,384 | -27.2% | 15,384 | 0.0% | 0.00% | – |
Q1 2023 | $29,383 | -21.4% | 15,384 | 0.0% | 0.00% | – |
Q4 2022 | $37,383 | +78.0% | 15,384 | 0.0% | 0.00% | – |
Q3 2022 | $21,000 | -34.4% | 15,384 | 0.0% | 0.00% | – |
Q2 2022 | $32,000 | -31.9% | 15,384 | 0.0% | 0.00% | – |
Q1 2022 | $47,000 | -4.1% | 15,384 | 0.0% | 0.00% | – |
Q4 2021 | $49,000 | +2.1% | 15,384 | 0.0% | 0.00% | – |
Q3 2021 | $48,000 | -5.9% | 15,384 | 0.0% | 0.00% | – |
Q2 2021 | $51,000 | -83.2% | 15,384 | -80.8% | 0.00% | – |
Q1 2021 | $304,000 | +8.2% | 80,331 | +11.3% | 0.00% | – |
Q4 2020 | $281,000 | +21.1% | 72,152 | 0.0% | 0.00% | – |
Q3 2020 | $232,000 | -9.7% | 72,152 | +9.4% | 0.00% | – |
Q2 2020 | $257,000 | +435.4% | 65,967 | +328.8% | 0.00% | – |
Q1 2020 | $48,000 | -34.2% | 15,384 | 0.0% | 0.00% | – |
Q4 2019 | $73,000 | -16.1% | 15,384 | 0.0% | 0.00% | – |
Q3 2019 | $87,000 | +77.6% | 15,384 | 0.0% | 0.00% | – |
Q2 2019 | $49,000 | -2.0% | 15,384 | 0.0% | 0.00% | – |
Q1 2019 | $50,000 | – | 15,384 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 1,817,654 | $10,215,000 | 12.02% |
GARRISON BRADFORD & ASSOCIATES INC | 15,500 | $87,000 | 0.12% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 224,400 | $1,261,000 | 0.02% |
Hartford Financial Management Inc. | 8,300 | $47,000 | 0.02% |
Virtu Financial LLC | 20,125 | $113,000 | 0.01% |
Larson Financial Group LLC | 2,350 | $13,000 | 0.01% |
A.R.T. Advisors, LLC | 16,137 | $91,000 | 0.01% |
BREWIN DOLPHIN LTD | 6,575 | $36,952 | 0.00% |
OPPENHEIMER & CO INC | 12,760 | $72,000 | 0.00% |
TRUEWEALTH LLC | 800 | $4,000 | 0.00% |